Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females.
about
Complementary and Alternative Therapies in Amyotrophic Lateral SclerosisScreening of Drugs Inhibiting In vitro Oligomerization of Cu/Zn-Superoxide Dismutase with a Mutation Causing Amyotrophic Lateral SclerosisVitamin D in amyotrophic lateral sclerosis.Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review.Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral SclerosisCharacterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis.State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model.Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.Vitamin D as a potential therapy in amyotrophic lateral sclerosis.ALSUntangled No. 24: Vitamin D.Vitamin D is Not a Protective Factor in ALS.Investigation of vitamin D receptor polymorphisms in amyotrophic lateral sclerosis.Vitamin D and Neurological Diseases: An Endocrine View.Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives
P2860
Q26777929-B20C3804-BE46-42D6-B3C3-82562A52B77BQ28831086-299185B8-743B-4269-83DE-B87715F4B5E7Q33894153-243AD857-30D4-4F91-BD76-F747C110E53FQ35630224-B7B2D3AA-0C56-46FE-A7B2-3ECF7B1F967FQ35645195-8DF4EBD0-10B1-47FA-ACBA-2895F92F8426Q36299228-7CA3A217-D747-487D-8AD8-9F196362B28DQ36494315-C9C7E63E-02F0-44EB-B3B7-C84F8C2AA78CQ36925891-803C963F-9DAA-4584-B232-C7392F5BCDB0Q38178758-03EDE000-450D-4F39-A467-BE495ACB431CQ38201127-470E1897-5C44-4367-8793-22C9D058AF8FQ41652246-DF5A5C0B-B1D0-4EA6-B0FE-7D60C397643EQ46698206-576AB1F1-23A1-43A6-ADF4-7DA7DC029616Q47171978-307B3045-4505-4B72-B029-8FE0823ED05FQ58787868-EAF28F95-15C1-4CA0-B05B-337E3CA4F439
P2860
Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@ast
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@en
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@nl
type
label
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@ast
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@en
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@nl
prefLabel
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@ast
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@en
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@nl
P2860
P1433
P1476
Vitamin D(3) at 50x AI attenua ...... ALS, and is toxic in females.
@en
P2093
Alexandro Gianforcaro
Jesse A Solomon
P2860
P304
P356
10.1371/JOURNAL.PONE.0030243
P407
P577
2013-02-06T00:00:00Z